Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microbial lipid bilayer membrane is a fundamental structural component of bacteria and fungi, serving as a selective barrier between the cytoplasm and the external environment (StatPearls: NBK553016). Beyond its role as a physical barrier, it is a metabolic hub responsible for energy production via the electron transport chain, nutrient uptake, and signal transduction (PubMed: 29124368). Microbial membranes differ significantly from mammalian membranes in their lipid composition; for instance, bacterial membranes are rich in anionic phospholipids like phosphatidylglycerol, and fungal membranes contain ergosterol instead of cholesterol (PubMed: 30612058). These unique features are exploited by various antimicrobial classes, including polymyxins, which target the lipopolysaccharides and phospholipids of Gram-negative bacteria, and daptomycin, which causes calcium-dependent depolarization in Gram-positive bacteria (PubMed: 24297485). Disruption of the membrane leads to the loss of essential ions, such as potassium, resulting in rapid cell death. Despite their efficacy, drugs targeting the microbial membrane often carry risks of systemic toxicity, such as nephrotoxicity and neurotoxicity, due to potential interactions with host cell membranes (PubMed: 27330062).
Membrane permeabilization, pore formation, and cellular depolarization leading to the rapid leakage of intracellular contents and cell death (PubMed: 30612058).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial lipid bilayer membrane.